These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6135172)
1. Influence of streptozotocin-induced diabetes on growth hormone secretion in the rat. Bluet-Pajot MT; Durand D; Kordon C Neuroendocrinology; 1983; 36(4):307-9. PubMed ID: 6135172 [TBL] [Abstract][Full Text] [Related]
2. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164 [TBL] [Abstract][Full Text] [Related]
3. Effect of streptozotocin diabetes and insulin replacement on growth hormone in rats. Gonzalez C; Jolin T J Endocrinol Invest; 1985 Feb; 8(1):7-11. PubMed ID: 3886772 [TBL] [Abstract][Full Text] [Related]
4. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats. Welsh JB; Szabo M Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949 [TBL] [Abstract][Full Text] [Related]
6. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats. Plotsky PM Neuroendocrinology; 1991 May; 53(5):433-8. PubMed ID: 1678493 [TBL] [Abstract][Full Text] [Related]
7. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin. Martin D; Epelbaum J; Bluet-Pajot MT; Prelot M; Kordon C; Durand D Neuroendocrinology; 1985 Dec; 41(6):476-81. PubMed ID: 2867482 [TBL] [Abstract][Full Text] [Related]
8. Suppression of episodic growth hormone secretion in streptozotocin-induced diabetic mice: time-course studies on the hypothalamic pituitary axis. Murao S; Sato M; Tamaki M; Niimi M; Ishida T; Takahara J Endocrinology; 1995 Oct; 136(10):4498-504. PubMed ID: 7664670 [TBL] [Abstract][Full Text] [Related]
9. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone. Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683 [TBL] [Abstract][Full Text] [Related]
10. Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats. Ortiz-Caro J; González C; Jolin T Endocrinology; 1984 Dec; 115(6):2227-32. PubMed ID: 6238818 [TBL] [Abstract][Full Text] [Related]
11. Development of hypothalamic control of growth hormone secretion in the rat. Khorram O; DePalatis LR; McCann SM Endocrinology; 1983 Aug; 113(2):720-8. PubMed ID: 6135598 [TBL] [Abstract][Full Text] [Related]
12. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Bruno JF; Xu Y; Song J; Berelowitz M Endocrinology; 1994 Nov; 135(5):1787-92. PubMed ID: 7956902 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro. Soya H; Suzuki M Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284 [TBL] [Abstract][Full Text] [Related]
15. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture. Cuttler L; Welsh JB; Szabo M Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023 [TBL] [Abstract][Full Text] [Related]
17. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor. Soya H; Suzuki M Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163 [TBL] [Abstract][Full Text] [Related]
18. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro. Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117 [TBL] [Abstract][Full Text] [Related]
19. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice. Park S; Peng XD; Frohman LA; Kineman RD Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497 [TBL] [Abstract][Full Text] [Related]
20. Presence of an adenylate cyclase dually regulated by somatostatin and human pancreatic growth hormone (GH)-releasing factor in GH-secreting cells. Spada A; Vallar L; Giannattasio G Endocrinology; 1984 Sep; 115(3):1203-9. PubMed ID: 6146515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]